Tyruko is a Tysabri biosimilar which has been FDA approved for multiple sclerosis. But is Tyruko just as good as Tysabri? Is it as effective and safe? Can you shift directly from Tyruko to Tysabri? This video explains Tyruko and reviews a head-to-head trial comparing Tysabri and Tyruko.
Open this video by clicking the arrow or click here
Selected sources: Tyruko product label: https://www.accessdata.fda.gov/drugsa… Novartis wins FDA nod for first biosimilar version of Biogen’s MS blockbuster Tysabri: https://www.fiercepharma.com/pharma/n… FDA Approves Biosimilar Tyruko for Multiple Sclerosis, Crohn Disease: https://www.empr.com/home/news/generi… Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis The Antelope Phase 3 Randomized Clinical Trial: https://jamanetwork.com/journals/jama… Natalizumab (Tysabri): https://www.ajnr.org/content/31/9/1588
- Catch-up and learn more about Multiple Sclerosis from MS Views and News (www.msvn.org)
- Read our blog containing thousands of articles relating to Multiple Sclerosis
- Sign-up with us so you can learn when and where live events are happening.